ClinicalTrials.govpublic full text
A Study to Evaluate Long-term Safety of CC-486 (Oral Azacitidine) in Subjects With Hematological Disorders
hematologic neoplasm, neoplasms, hematologic malignancies, cc-486, oral azacitidine, hematological disorders, rollover study, open label, onureg, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 915065
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.